alseroxylon (rauwiloid) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drugs@FDA PubChem

Active Ingredient History

NOW
  • Now
Alseroxylon is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension and angina pectoris and as a sedative in psychoses. It was at one time approved for use in the United States, but has since been discontinued.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Oral
  • Pro Drug: No

Alternative names

alkaloids, rauwolfia | hiwolfia | hyserpin | koglucoid | rauserpin | rauvolfia serpentina root | rauwiloid | rauwolfia | rauwolfia alkaloids | rauwolfia alkaloids, whole root | rauwolfia root | rauwolfia serpentina | rauwolfia serpentina alseroxylon | rauwolfia serpentina root | snakeroot | wolfina

Organizations (4)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (4)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue